{"url_path":"/sec/vtvt/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 OTHER INFORMATION","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1641489/0001641489-26-000020-index.html","accession_number":"0001641489-26-000020","cik":"0001641489","ticker":"VTVT","issuer_name":"vTv Therapeutics Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1641489/0001641489-26-000020-index.html","primary_entity_key":"0001641489","primary_entity_name":"vTv Therapeutics Inc."},"word_count":60,"has_tables":true,"body_markdown":"ITEM 5.    OTHER INFORMATION\n\nRule 10b5-1 Trading Plans\n\nDuring the first fiscal quarter ended March 31, 2026, none of our directors or executive officers adopted or terminated any contract, instruction or written plan for the purchase or sale of our securities to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any “non-Rule 10b5-1 trading arrangement.”\n\n26\n\n[Table of Contents](#idd81345c511d42b59f017f1a6041b531_7)"}